Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

10-Year knee study tests if new treatment outlasts surgery

NCT ID NCT06916728

Disease control Sponsor: Smith & Nephew, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study follows 170 people for 10 years to see if a marketed product (MP01) works better than standard knee surgery for joint surface lesions. Participants had already been in an earlier trial. Researchers will measure knee pain, function, and quality of life, and track any additional procedures needed. The goal is to confirm long-term benefits and safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 170 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Feb 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Up to 170 subjects who had joint surface lesions of the knee, participated in the pivotal study and consent to continue follow-up will be enrolled.

Ages

21 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Participated in the pivotal study. 2. Must be physically and mentally willing and able to comply with the follow-up schedule. 3. Signed and dated the IEC/IRB approved Informed Consent Form and HIPPA (if applicable). Exclusion Criteria: 1. Withdrawn from the pivotal study due to index knee requiring a unicompartmental or total knee arthroplasty. 2. Chemotherapy in the past 12 months. 3. Participation in other clinical trials involving knee procedures. 4. Vulnerable individual including prisoners (i.e., unable to fully understand all aspects of the study that are relevant to the decision to participate or could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Joint surface knee lesions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Knee Injuries

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Joint surface knee lesions Knee injuries

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites in 6 countries. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • AZ Monica

    Antwerp, 2018, Belgium

  • County Hospital Timis Othopedy and Trauma Clinic II

    Timișoara, 300736, Romania

  • Hadassah Medical Center

    Jerusalem, 9103401, Israel

  • Horizon Clinical Research

    La Mesa, California, 91942-3026, United States

  • Humanitas Gavazzeni

    Bergamo, 24125, Italy

  • Institut za Ortopedsko hiruske Bolesti "Banjica"

    Belgrade, 11000, Serbia

  • Istituto Clinico Humanitas

    Milan, 20089, Italy

  • Klinika Orto MD

    Novi Sad, 21000, Serbia

More trials for these conditions

Other studies related to the condition(s) this trial covers.